Open but Not Whole: A Review of the Value and Limitations of Public Databases in Research

A narrative review for early-career researchers, students and practitioners who build their work on data they did not collect themselves. It opens by sorting public databases into five kinds (primary repositories, aggregators, cohort and clinical resources, registries, and official and survey statistics). It then shows what they have made possible: the Protein Data Bank's role in AlphaFold, real-time genomic surveillance during COVID-19, reproducible analysis, and lower-cost research in low-resource settings. Next it sets out eight ways a database can differ systematically from the reality it appears to describe, each illustrated with published cases: GBIF records clustering near roads and cities, UK Biobank's healthier-than-average participants, fungal sequences filed under the wrong species, gene names silently converted to dates by spreadsheets, research data that disappear as papers age, re-identification attacks that force deliberate gaps in privacy-protected releases, and the retracted Surgisphere-based COVID-19 study. The paper ends with ten practical checks for people who use public data and a set of practices for those who contribute to it.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-06
DOI
https://doi.org/10.5281/zenodo.23181391
Primary Topic
Research Data Management Practices
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Open but Not Whole: A Review of the Value and Limitations of Public Databases in Research

Raunak Sharma, Sreemoyee Chakraborty
Zenodo (CERN European Organization for Nuclear Research)
Research Data Management Practices
preprint

Open but Not Whole: A Review of the Value and Limitations of Public Databases in Research

Raunak Sharma, Sreemoyee Chakraborty
preprint en

Abstract

A narrative review for early-career researchers, students and practitioners who build their work on data they did not collect themselves. It opens by sorting public databases into five kinds (primary repositories, aggregators, cohort and clinical resources, registries, and official and survey statistics). It then shows what they have made possible: the Protein Data Bank's role in AlphaFold, real-time genomic surveillance during COVID-19, reproducible analysis, and lower-cost research in low-resource settings. Next it sets out eight ways a database can differ systematically from the reality it appears to describe, each illustrated with published cases: GBIF records clustering near roads and cities, UK Biobank's healthier-than-average participants, fungal sequences filed under the wrong species, gene names silently converted to dates by spreadsheets, research data that disappear as papers age, re-identification attacks that force deliberate gaps in privacy-protected releases, and the retracted Surgisphere-based COVID-19 study. The paper ends with ten practical checks for people who use public data and a set of practices for those who contribute to it.

Zenodo (CERN European Organization for Nuclear Research)
Research Data Management Practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.